FindMyKOL
Clinical trialNCT02738866Active, not recruitingPhase 2Interventional

Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment60Metastatic Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) after disease progression of palbociclib in combination with an aromatase inhibitor.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital

    Washington D.C., District of Columbia, United States

  • Anne Arundel Health System Research Institute, Inc.

    Annapolis, Maryland, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland, United States

  • Allegheny Health Network (ahn) - Allegheny General Hospital Only

    Pittsburgh, Pennsylvania, United States

  • Reading Hospital - Mcglinn Cancer Institute

    West Reading, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fulvestrant →Palbociclib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Oct 2016
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
5 Jun 2026
Registered enrollment
60
Registry id
NCT02738866
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.